Sep 30, 2026 04:06PM
Sep 30, 2026 07:47AM
Sep 30, 2026 07:45AM
Aug 11, 2026 04:02PM
Aug 6, 2026 04:02PM
Jul 20, 2026 07:30AM
Jul 20, 2026 07:30AM Immunome Announces First Patient Dosed in Phase 1 Trial Evaluating IM-3050, an FAP-Targeted Radioligand Therapy, in Patients with FAP-Expressing Advanced Solid Tumors
Jul 9, 2026 06:48AM
Jul 8, 2026 07:30AM
Jul 8, 2026 07:30AM
Jul 7, 2026 04:02PM
Jun 11, 2026 07:30AM
Jun 11, 2026 07:30AM
Jun 4, 2026 04:02PM Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 30, 2026 08:00AM
May 30, 2026 08:00AM
May 27, 2026 08:00AM
May 12, 2026 04:02PM
Apr 29, 2026 07:30AM
Apr 29, 2026 07:30AM
Apr 21, 2026 10:30AM Immunome to present Phase 3 desmoid tumor trial data at 2026 ASCO
Apr 21, 2026 10:30AM
Mar 3, 2026 04:02PM
Feb 5, 2026 09:26AM
Dec 16, 2025 12:18PM
Dec 16, 2025 07:20AM
Dec 15, 2025 07:00AM
Dec 15, 2025 07:00AM Immunome Announces Positive Topline Results from Phase 3 RINGSIDE Trial of Varegacestat in Patients with Desmoid Tumors
Nov 17, 2025 07:08AM
Aug 6, 2025 04:05PM
Feb 11, 2025 08:30AM
Jan 13, 2025 08:00AM
Oct 29, 2024 08:00AM
Oct 18, 2024 08:00AM
Jul 25, 2024 08:00AM Immunome Provides Update on Recent Business Development Activity Expected to Expand ADC Capabilities
Mar 26, 2024 08:00AM
Feb 20, 2024 08:00AM
Feb 6, 2024 08:00AM
Feb 6, 2024 08:00AM
Nov 9, 2023 08:00AM
Oct 3, 2023 08:05AM
Oct 3, 2023 08:00AM Immunome and Morphimmune Announce Successful Completion of Merger with $125 Million PIPE to Develop Novel Targeted Cancer Therapies
Jun 29, 2023 09:01AM
Jun 29, 2023 09:00AM
May 23, 2023 04:07PM
May 23, 2023 04:05PM
May 5, 2023 08:00AM
Mar 16, 2023 08:00AM
Mar 9, 2023 08:45AM Immunome to Present at 13th Annual World ADC London Conference
Feb 8, 2023 08:00AM

332,933 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All